Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Navidea BiopharmaceuticalsDestiny PharmaCAN-FITE BIOPHA/SAgronomicsCrescita Therapeutics
SymbolNYSEAMERICAN:NAVBLON:DESTNYSEAMERICAN:CANFLON:ANICTSE:CTX
Price Information
Current Price$2.85GBX 38.50$1.92GBX 7.20C$0.60
52 Week RangeBuyN/ABuyN/AN/A
Beat the Market™ Rank
Overall Score1.20.51.30.60.9
Analysis Score3.50.03.50.00.0
Community Score2.62.52.82.52.5
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.00.0
Earnings & Valuation Score0.00.00.00.61.9
Analyst Ratings
Consensus RecommendationBuyN/ABuyN/AN/A
Consensus Price Target$5.00N/A$5.00N/AN/A
% Upside from Price Target75.44% upsideN/A160.42% upsideN/AN/A
Trade Information
Market Cap$52.60 million£16.67 million$15.61 million£16.01 millionC$15.12 million
BetaN/AN/AN/AN/AN/A
Average Volume1,029,1134,205933,853N/A44,839
Sales & Book Value
Annual RevenueN/A£305,906.00N/A£-44,040.00C$22.34 million
Price / SalesN/A55.21N/A-412.210.55
CashflowN/AGBX 17.79 per shareN/AGBX 13.71 per shareC$0.44 per share
Price / CashN/A2.16N/A0.531.37
Book ValueN/AGBX 17.70 per shareN/AGBX 13.90 per shareC$1.02 per share
Price / BookN/A0.02N/A0.010.59
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSN/AGBX (10.70)N/AGBX (1.30)C$0.09
Trailing P/E Ratio0.00N/A0.00N/A6.90
Forward P/E Ratio
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/A7.33%
Current RatioN/A10.68%N/A119.70%3.67%
Quick RatioN/A10.51%N/A119.70%2.74%
Ownership Information
Institutional Ownership PercentageN/AN/A5.12%N/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees14N/A7N/A62
Shares Outstanding21.65 million43.87 million8.67 million252.14 million20.65 million
Next Earnings Date8/13/2020 (Estimated)N/A9/4/2020 (Estimated)N/AN/A
OptionableOptionableOptionableOptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.